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ABSTRACT
 
Oral hairy leukoplakia (OHL) is defined as an asymptomatic white patch with vertical corrugation pattern the 
lateral borders of the tongue, that is associated with Epstein-Barr Virus (EBV) infection. Generally, it is related to 
immunosuppressive condition found in HIV-positive patients and patients undergoing immunosuppressive therapy. 
Sometimes, its clinical appearances could mimic other white lesions. Although most OHL cases are found in HIV 
seropositive individuals, finding in the immunocompetent individuals has also been reported. Appropriate clinical 
evaluations and laboratory investigations are important for patient’s comprehensive management. Objective: To 
report a finding of oral hairy leukoplakia as a clinical indicator of an immunosuppressive condition in otherwise a 
clinically healthy-looking individual and to discuss the challenges on patient management. Case Report: A 40 year-
old man presented with asymptomatic, bilateral homogenous white hyperkeratotic plaques with a hairy appearance 
located on the dorsal of the tongue, extended to the lateral tongue mucosa. The patient failed to remember the lesion’s 
first appearance, until three weeks before a visit. Working diagnosis of OHL was made with differential diagnoses 
including white sponge nevus, leukoplakia and oral lichen planus. Histopathological assessment was consistent 
with OHL. Challenges on patient management include identifying possible risk factors and assuring patient for 
HIV testing. Conclusion: This case reported findings of OHL as the first clinical indicator of immunosuppressive 
condition that might be related to HIV-infection. 
Keywords: Acquired Immunodeficiency Syndrome, Epstein-Barr Virus, Human Immunodeficiency Virus, 
oral hairy leukoplakia
INTRODUCTION
Oral hairy leukoplakia (OHL) is a white lesion commonly 
found in individuals with immunodeficiency. OHL is 
a unique white lesion presenting as an asymptomatic 
white patch with a vertical corrugation pattern on 
the lateral border of the tongue and associated with 
Epstein-Barr Virus (EBV) infection.1 OHL could 
be an early indicator  of immunosuppresion such as 
hematologic malignancies, long-term uses of systemic 
steroid, undiagnosed HIV/AIDS. It is an indicator 
of those who in the progression of state of AIDS for 
example seropositive homosexual men.2 In general, 
OHL is recognized as a form of an opportunistic 
infection associated with HIV infection. The ability to 
recognize the manifestations of systemic conditions is 
a key in providing a comprehensive care with an early 
appropriate medical intervention in order to reduce the 
mortality rate of patients and enhancing the quality 
of life.3,4
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OBJECTIVE 
The objective of this case report was to present a finding 
of OHL as a clinical indicator of an immunosuppressive 
condition in a clinically healthy-looking individual and 
to discuss the challenges on patient management. 
CASE REPORT
A 40 year-old man who looked apparently healthy 
came to the Dental Hospital Universitas Indonesia, 
complaining of the appearance of asymptomatic 
bilateral white plaques located on the dorso lateral 
borders of his tongue. The patient failed to remember 
the lesion’s first appearance, until three weeks before 
this visit. The patient was worried that the appearance 
of white patches on the tongue was a sign of malignancy 
especially cancer of the tongue or HIV infection. He 
had never been tested for HIV before. He denied any 
medical problems, risks or lifestyles associated with 
HIV infection. The patient reported no fever or pain 
when swallowing or chewing. Numbness and a burning 
sensation on the tongue were also denied. The intraoral 
examination showed bilateral white hyperkeratotic 
homogenous patches on the lateral borders of the 
tongue along the region of teeth 34-37 and 44-47. The 
lesions appeared to spread downwards to the ventral 
surfaces of the tongue and were unscrapable, painless, 
hairy or corrugated in appearance and showed no 
induration or erythema (Figure 1 a-d). 
 
The working diagnosis of oral hairy leukoplakia was 
made with differential diagnoses of white sponge 
nevus, leukoplakia and oral lichen planus. In order 
to obtain the definitive diagnosis, the patient was 
scheduled for biopsy for histopathology examination. 
On the following visit, the intraoral examination 
revealed white patches with erythematous borders 
that could be scrapped off on the soft palate and both 
sides of buccal mucosae. These clinical appearances 
were consistent with pseudomembranous candidiasis. 
Figures 1(a)-(d). The homogenous hairy white patches along 
the dorsolateral border and ventral tongue surfaces.
Figure 2. (a) The clinical feature reveals the lesion on the 
right dorsolateral surface of the tongue where the biopsy 
was performed; (b) The clinical feature showed a completely 
healed wound on the following visit.
Figure 3. (a) Ballooning degeneration of the epithelial cells 
in the stratum spinosum was demonstrated (H&E, original 
magnification x100); (b) Higher magnification showed 
perinuclear halos and peripheral margination of the chromatin 
in the nuclei of the spinous cells (H&E, original magnification 
x400).
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On that visit, the patient was prescribed with nystatin 
oral suspension four times daily for two weeks. He 
was scheduled for biopsy and basic blood laboratory 
tests in two-week time at the Department of Oral and 
Maxillofacial Surgery. 
On the day of the biopsy, intraoral examination 
showed that the pseudomembranous candidiasis 
lesion did not completely disappear. The patient 
admitted that he was not properly adhered on taking 
medication prescribed. He was then prescribed 
with twice daily 50 mg of Fluconazole orally for 
7 days. Biopsy was performed (Figure 2a) and the 
specimen was sent for histopathological assessment 
at the Department of Anatomic Pathology, Faculty of 
Medicine, University of Indonesia. On the following 
visit, intraoral examination showed complete healing of 
the wound at the operation site (Figure 2 a,b). Finally, 
the histopathological assessment confirmed that the 
white lesion was consistent with OHL exhibiting the 
ballooning spinous cells without any sign of dysplastic 
changes (Figure 3 a,b). 
Two weeks after the biopsy, the patient was scheduled 
for private consultation about the results of the 
histopathologic assessment of OHL. The patient was 
concerned about the definitive diagnosis of the lesion 
and its connection with HIV infection. The patient was 
then given explanations about OHL as an indicator 
of HIV infection and a lifestyle related to the lesion. 
Unexpectedly, the patient became uneased and worried 
about what he was told. He decided to leave the clinic 
and asked for another appointment. We informed the 
patient that the diagnosis of HIV infection could not 
be done only by having a clinical examination. In fact, 
he still needed some tests to confirm the diagnosis. 
In addition, it was essential for him to have pre- and 
post-counseling about HIV infection and referral to 
the internal medicine when the definitive diagnosis 
was made. Reassurance and supports were given to the 
patient continuously. Although the patient did not decide 
to be scheduled for another appointment, he promised 
he would receive the treatment when he was ready. In 
fact, for two months, we got communication by phone, 
for consulting the test and assuring medication. Then 
after 3 months, the patient came to the Dental Hospital, 
and give the result of the test. He told us that he was 
positive HIV, in which CD4 is 38. He also took the ARV 
medication. On the oral examination, the lesion of OHL 
was remission after he consumed ARV medication. The 
manajement of this patient was completely resolved, 
with the remission of the OHL lesion, and the patient 
was under ARV treatment by internist. 
The lesion of OHL can be diagnosed by clinically and 
histopathological examination. We confirm that in 
most cases, oral hairy leukoplakia can be diagnosed 
clinically and does not require a confirmatory biopsy. 
It does not require specific treatment and frequently 
resolves under HAART or ARV medication, if 
associated with HIV infection. 
DISCUSSION
Oral hairy leukoplakia is one of the most common 
early lesions in immunocompromised patients. OHL is 
a flat, corrugated or hairy lesion usually located on the 
lateral border of the tongue, unilaterally or bilaterally. 
OHL cannot be removed by scraping.5,6 Generally, 
OHL is related to immunosuppressive conditions 
found in HIV-positive patients and patients undergoing 
immunosuppressive therapy. Although most OHL cases 
are found in HIV-seropositive individuals, finding 
in the absence of immunosuppression has also been 
reported. Previous studies have suggested that OHL 
is an early indicator of HIV infection and be related 
to the progression of AIDS.1 Although typically, 
the clinical feature of OHL is unique, its clinical 
appearances in some cases may mimic other oral white 
lesions suggesting a confirmation of the diagnosis by 
histopathologic examination in those cases. Oral white 
lesions that could have similar appearances to OHL 
include oral white sponge nevus, chronic hyperplastic 
candidiasis, pseudomembranous candidiasis, oral 
lichen planus, idiopathic oral leukoplakia, frictional 
keratosis, geographic tongue and “galvanic” lesions.3,6 
Etiologically, OHL is believed to be associated with 
an infection with EBV, a double-stranded DNA virus 
that can replicate in the epithelial cells as a primary 
site. Based on the histopathological examination, an 
absence or a high reduction of Langerhans cells in the 
lesion was reported. Langerhans cells are the antigen-
presenting immune cells that are responsible for viral 
infection.7 Detection of EBV DNA in the epithelial cells 
was studied in 25 OHL cases by using noninvasive 
diagnostic techniques, the filter in situ hybridization 
(FISH) and cytospin in situ hybridization (CISH). 
The results showed that all cases were EBV-positive 
by FISH, and 23 cases were EBV-cases by CISH.8 By 
combined methods of immunohistochemistry, DNA 
in situ hybridization, and lectin histochemistry, the 
life cycle of EBV in the keratinocytes, in which both 
EBV protein and DNA were found, was identified.9 
Moreover, the pathogenesis of OHL was suggested 
to be involved in a migration of the EBV-infected 
monocytes/macrophages from the submucosa into the 
spinosum or granulosum layer of the oral epithelium.10
As the AIDS disease progresses, reflected by a continual 
loss of CD4 lymphocytes, the oral cavity becomes more 
susceptible to various oral lesions as shown in Table 1.11 
Candidiasis was the most common lesion seen in patients 
with CD4+ counts less than 200 (28 cases), followed by 
periodontitis (7 cases). OHL was found in three patients 
with CD4+ counts less than 200, and one patient with 
CD4+ counts at the range of 200- 499.11 
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Table 1. Oral manifestations related to CD4+ counts
CD4+ count
cell/mm3
Periodontitis Gingivitis Herpes Candidiasis Hairy
Leukoplakia
Ulceration Kaposi’s
Sarcoma
Non Hodgkin
Lymphoma
<200 7 3 3 28 3 1 3 1
>200 <499 9 2 2 9 1 3 0 0
>500 1 0 0 1 0 0 0 0
The histology examination of OHL shows acanthotic 
parakeratinized stratified squamous epithelium with 
finger-like projections, giving a clinical feature of 
a corrugated or hairy appearance. Typically, the 
upper spinous cell layer reveals the presence of the 
koilocytes occurred by ballooning degeneration of the 
epithelial cells.12,13 Microscopically, the koilocytes are 
the vacuolated spinous cells with pyknotic nuclei and 
perinuclear halos.
There is a specific patient’s management of OHL 
especially for undiagnosed HIV infection, especially 
good communication by giving the right information 
about the risk factors of OHL including HIV infection. 
The dentists who are get involved need to be skillful 
in interviewing patients and good listeners to get 
the information about patient’s lifestyle that might 
be related to a risk factor for HIV infection. For 
undiagnosed HIV-infected persons, the principal 
patients’ management focuses on restoring the patient’s 
comfort, eliminating secondary infections of bacteria, 
viruses and fungi, and preventing the possibility 
of other oral diseases.5 The pre-test counseling for 
undiagnosed HIV patients with a consideration of the 
human rights is also needed.14 
There are three principles of HIV testing, (the 
“three Cs”) are established as norms: counseling 
and information providing about HIV/AIDS before 
and after the test; consent to tests by suspicious 
individuals in an informed, specific, and voluntary 
way; and confidentiality of the test results and the fact 
of seeking a test.14 Moreover, the strategies of relaxing 
counseling by reducing stigma and discrimination 
related to HIV infection or AIDS would give patient’s 
confidence to talk about history of his/her life style 
and lead to patient’s decision making to have a test 
for HIV infection.14 There are rapid HIV screening 
tests for antibodies against the HIV in individuals 
who have initially infected within a month and a half 
to up to six months. It is important to note that during 
the initial infection before the development of the 
antibodies, a stage known as “acute HIV infection,” 
those individuals will not have a positive test result 
and could make a greater risk of transmission. 15 It was 
reported that undiagnosed HIV infection is a major 
drive of the transmission of HIV causing the incidence 
of HIV infection in the United States of over 50,000 
annually. It was described that 18 % of infected persons 
nationally are unaware of their HIV status. In fact, 
44-66 % of new HIV infections are attributed to this 
modest proportion of individuals with undiagnosed 
HIV.16 Therefore, to eliminate the global HIV/AIDS 
epidemic, there is a need for an action to promote the 
“seek, test, treat, and retain” (STTR) strategy. This 
strategy consists of seeking people at risk who have 
not been recently tested for HIV infection (seeking), 
engaging them in HIV testing (testing), initiating, 
monitoring, and maintaining treatment for those 
testing positive (treating) and retaining patients in 
care (retaining).16 One of the seeking strategies is to 
detect the oral lesion that could show a clinical sign 
of the immunodeficiency status of HIV. In 2009, the 
Government of Canada initiated the Seek and Treat 
Strategic for Optimal Prevention of HIV/AIDS in BC 
(STOP HIV/AIDS in the British Columbia province, 
BC). As a result, the morbidity, mortality, and new 
HIV diagnoses have continued to decrease steadily 
in BC.17 In China, the number of people being tested 
for HIV had increased almost four folds b 2007 to 101 
million in 2012, between 2007 to 2012. The number 
of newly identified HIV cases had increased from 
48,074 to 82,434 cases. Subsequently, started in 2011, 
China has taken further steps to promote HIV testing 
and treatment particularly targeting people at risk of 
HIV infection in each province across the nation. This 
effort has significantly improved the identification of 
infected individuals and the number of new patients 
receiving earlier treatment has increased, leading to 
a reduction in the mortality rate of patients.17 In an 
Asia-Pacific region, there were 350000 newly HIV-
infected individuals especially who were the drug 
users and homosexuals or transgender persons. HIV-
infected homosexuals in Indonesia, India, Malaysia 
and some certain other Asian countries are considered 
inaccessible and victimized because of the stigma, 
discrimination, and injustice against.4  Collectively, 
a proper management and counselling in newly HIV-
infected individuals have to be established and a 
screening of the oral cavity of HIV-infected persons 
is suggested to be regularly performed.4 
In Indonesia, the Ministry of Health of Indonesia 
reported that there were totally 150,296 HIV-infected 
individuals and 55,799 patients with AIDS from 
1987 until September 2014 and 7335 HIV-infected 
individuals and 176 patients with AIDS during 
the quarter of July to September 2014. The modes 
of transmission include heterosexual (34,305), 
homosexual/bisexual (1,366), Injecting Drug Users 
(IDU) (8,462), blood transfusion (130) and perinatal 
transmission (1,506), and unknown (9,536).18 The AIDS 
epidemic in Indonesia (2007) showed the prevalence 
of HIV infection among different groups of people 
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as follows; 10.4% among direct sex workers; 4.6% 
among indirect sex workers; 24.4% among transgender; 
0.8% among the clients of female sex workers; 5.2% 
among MSM; and 52.4% among IDU. Interestingly, 
it was found that the transmission of HIV infection 
is rising among MSM.19 To eliminate the rising of 
the transmission, the interventions of Government of 
Indonesia is needed by providing supportive policies 
to the key populations, promoting the use of condoms, 
and reducing stigma and discrimination against HIV-
infected individuals and patients with AIDS especially 
the MSM group.19 
CONCLUSION
In summary, OHL could be an early sign of undiagnosed 
immunosuppression, particularly who might be 
undergoing the progression of HIV infection as 
reported here. The goal of the patient’s management 
was to establish the definitive diagnosis and to assure 
the patient to immediately have tests for HIV infection 
and CD4 counts. 
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